A Randomised, Double-Blind, Vehicle Controlled, Single Center, Parallel Group, Comparative Study of the Efficacy of Penciclovir 10mg/g (1%) Cream in Preventing the Appearance of Classical Lesion in Recurrent Cold Sore Sufferers.

Trial Profile

A Randomised, Double-Blind, Vehicle Controlled, Single Center, Parallel Group, Comparative Study of the Efficacy of Penciclovir 10mg/g (1%) Cream in Preventing the Appearance of Classical Lesion in Recurrent Cold Sore Sufferers.

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Nov 2012

At a glance

  • Drugs Penciclovir (Primary)
  • Indications Herpes labialis
  • Focus Therapeutic Use
  • Sponsors Novartis
  • Most Recent Events

    • 09 Dec 2009 Planned end date changed from 1 Nov 2009 to 1 Mar 2010 as reported by ClinicalTrials.gov.
    • 04 Dec 2009 Actual patient number (126) added as reported by ClinicalTrials.gov.
    • 14 Jan 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top